Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MED | MEDIFAST INC | 2025-10-16 15:10:05 | 12.86 | 0.02 | 0.16 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MED | 0000910329 | MEDIFAST INC | US58470H1014 | 5299000YHQJ21T5KKI80 | 133714405 | NYSE | 2090 | Miscellaneous Food Preparations & Kindred Products | 1231 | DE | 100 INTERNATIONAL DRIVE | BALTIMORE | MD | 21202 | UNITED STATES | US | 4105818042 | 100 INTERNATIONAL DRIVE, BALTIMORE, MD, 21202 | 100 INTERNATIONAL DRIVE, BALTIMORE, MD, 21202 | HEALTHRITE INC | Weight loss | 1981 | — | 713 | http://medifastinc.com | 230,000,000 | 10,991,000 | 10,991,064 | Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. | 2025-10-10 22:39:09 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 230,000,000 | -770,000,000 | -77 | 10,937,830 | 42,235 | 0.3876 |
| 2023 | 1,000,000,000 | -1,000,000,000 | -50 | 10,895,595 | 50,751 | 0.468 |
| 2022 | 2,000,000,000 | -1,300,000,000 | -39.3939 | 10,844,844 | -697,786 | -6.0453 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jason L. Groves | Chief Legal Officer, Corporate Secretary | 2023 | 427,781 | 0 | 805,133 | 344,364 | 54,866 | 1,632,143 |
| Daniel R. Chard | Chairman, Chief Executive Officer | 2023 | 1,000,000 | 0 | 4,604,755 | 1,322,500 | 111,807 | 7,039,062 |
| James P. Maloney | Chief Financial Officer | 2023 | 527,085 | 0 | 992,101 | 424,303 | 66,334 | 2,009,824 |
| James P. Maloney | Chief Financial Officer | 2022 | 506,761 | 0 | 602,572 | 302,547 | 14,603 | 1,426,483 |
| Daniel R. Chard | Chairman, Chief Executive Officer | 2022 | 980,624 | 0 | 4,002,009 | 943,000 | 14,603 | 5,940,235 |
| Fiscal Year | Employee Count |
|---|---|
| 2020 | 713 |
| 2019 | 550 |
| 2018 | 420 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 602,463,000 | 1,072,054,000 | 1,598,577,000 |
| Cost Of Revenue | 157,840,000 | 296,204,000 | 458,163,000 |
| Gross Profit | 444,623,000 | 775,850,000 | 1,140,414,000 |
| Research And Development Expenses | 4,600,000 | 4,600,000 | 4,500,000 |
| General And Administrative Expenses | 441,745,000 | 649,448,000 | 955,608,000 |
| Operating Expenses | — | — | — |
| Operating Income | 2,878,000 | 126,402,000 | 184,806,000 |
| Net Income | 2,091,000 | 99,415,000 | 143,568,000 |
| Earnings Per Share Basic | 0.19 | 9.13 | 12.82 |
| Earnings Per Share Diluted | 0.19 | 9.1 | 12.73 |
| Weighted Average Shares Outstanding Basic | 10,930,000 | 10,884,000 | 11,195,000 |
| Weighted Average Shares Outstanding Diluted | 10,963,000 | 10,921,000 | 11,276,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 90,928,000 | 94,440,000 | 87,691,000 |
| Marketable Securities Current | 71,416,000 | 5,662,000 | 0 |
| Accounts Receivable | — | — | — |
| Inventories | 42,421,000 | 54,591,000 | 118,856,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 214,404,000 | 224,029,000 | 222,784,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 37,527,000 | 51,467,000 | 57,185,000 |
| Other Assets Non Current | 9,667,000 | 14,650,000 | 12,456,000 |
| Total Assets Non Current | 69,809,000 | 85,879,000 | 93,429,000 |
| Total Assets | 284,213,000 | 309,908,000 | 316,213,000 |
| Accounts Payable | 23,051,000 | 39,193,000 | 58,667,000 |
| Deferred Revenue | 316,000 | 574,000 | 7,357,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 64,161,000 | 92,300,000 | 140,894,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | 9,943,000 | 16,127,000 | 20,275,000 |
| Total Liabilities | 74,104,000 | 108,427,000 | 161,169,000 |
| Common Stock | 11,000 | 11,000 | 11,000 |
| Retained Earnings | 176,782,000 | 174,649,000 | 139,852,000 |
| Accumulated Other Comprehensive Income | 180,000 | 248,000 | 24,000 |
| Total Shareholders Equity | 210,109,000 | 201,481,000 | 155,044,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 12,707,000 | 13,107,000 | 10,980,000 |
| Share Based Compensation Expense | 7,363,000 | 8,188,000 | 11,053,000 |
| Other Non Cash Income Expense | -89,000 | -1,172,000 | -2,130,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | -12,170,000 | -64,265,000 | -61,187,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -396,000 | 4,694,000 | 3,412,000 |
| Change In Accounts Payable | -34,994,000 | -35,707,000 | -37,594,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 24,476,000 | 147,657,000 | 194,570,000 |
| Purchases Of Marketable Securities | 46,595,000 | 54,564,000 | — |
| Sales Of Marketable Securities | 27,529,000 | 0 | 5,267,000 |
| Acquisition Of Property Plant And Equipment | 7,454,000 | 6,483,000 | 16,681,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -26,520,000 | -61,047,000 | -11,414,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 715,000 | 1,407,000 | 19,641,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 0 | 3,602,000 | 126,445,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -1,515,000 | -79,789,000 | -199,581,000 |
| Change In Cash | -3,512,000 | 6,749,000 | -16,492,000 |
| Cash At End Of Period | 90,928,000 | 94,440,000 | 87,691,000 |
| Income Taxes Paid | -1,617,000 | 34,255,000 | 37,212,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.19 | 9.13 | 12.82 |
| Price To Earnings Ratio | 92.7368 | 7.3625 | 8.9977 |
| Earnings Growth Rate | -97.9189 | -28.7832 | -8.4939 |
| Price Earnings To Growth Ratio | -0.9471 | -0.2558 | -1.0593 |
| Book Value Per Share | 19.2231 | 18.5117 | 13.8494 |
| Price To Book Ratio | 0.9166 | 3.6312 | 8.3289 |
| Ebitda | 13,181,000 | 146,777,000 | 191,760,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | 0.0037 | 0.0019 | 0.0152 |
| Dividend Payout Ratio | 0.3419 | 0.0142 | 0.1368 |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | -1,233,000 | 7,389,000 | 12,034,000 |
| Free Cash Flow | 25,709,000 | 140,268,000 | 182,536,000 |
| Return On Equity | 0.01 | 0.4934 | 0.926 |
| One Year Beta | 0.6451 | 1.0725 | 0.972 |
| Three Year Beta | 0.9197 | 1.0494 | 0.9742 |
| Five Year Beta | 0.9527 | 0.9986 | 0.9852 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| BROWN JEFFREY J | Director | 2025-06-25 | 11,167 | A | 29,128 |
| BROWN JEFFREY J | Director | 2025-06-25 | 9,449 | A | 38,577 |
| Geary Elizabeth A. | Director | 2025-06-25 | 11,168 | A | 19,545 |
| Hoer Michael A. | Director | 2025-06-25 | 11,168 | A | 26,139 |
| Thomas Andrea B | Director | 2025-06-25 | 11,168 | A | 24,017 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CWM, LLC | 2025-09-30 | 217,000 | 15,849 | 13.6917 |
| MJT & Associates Financial Advisory Group, Inc. | 2025-09-30 | 1,367 | 100 | 13.67 |
| Farther Finance Advisors, LLC | 2025-09-30 | 875 | 64 | 13.6719 |
| EXCHANGE TRADED CONCEPTS, LLC | 2025-09-30 | 262,901 | 19,232 | 13.67 |
| Rise Advisors, LLC | 2025-09-30 | 684 | 50 | 13.68 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Small Cap Fund | CFSLX | 873 | 12,248.19 | 0.0026 |
| Advisors' Inner Circle Fund III | 2025-07-31 | I Shares | KCXIX | 47 | 647.19 | 0.0003 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2025-07-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 40,246 | 554,187.42 | 0.0234 |
| Global X Funds | 2025-07-31 | Global X Russell 2000 ETF | RSSL | 5,736 | 78,984.72 | 0.006 |
| FIDELITY CONCORD STREET TRUST | 2025-07-31 | Fidelity ZERO Total Market Index Fund | FZROX | 4,771 | 65,696.67 | 0.0002 |